TY  - JOUR
AU  - de Azevedo Lopes, Erivelton
AU  - Balbi, Gustavo Guimarães Moreira
AU  - Tektonidou, Maria G
AU  - Pengo, Vittorio
AU  - Sciascia, Savino
AU  - Ugarte, Amaia
AU  - Belmont, H Michael
AU  - Gerosa, Maria
AU  - Fortin, Paul R
AU  - Lopez-Pedrera, Chary
AU  - Ji, Lanlan
AU  - Cohen, Hannah
AU  - de Jesús, Guilherme Ramires
AU  - Branch, D Ware
AU  - Nalli, Cecilia
AU  - Petri, Michelle
AU  - Rodriguez, Esther
AU  - Kello, Nina
AU  - Ríos-Garcés, Roberto
AU  - Knight, Jason S
AU  - Atsumi, Tatsuya
AU  - Willis, Rohan
AU  - Bertolaccini, Maria Laura
AU  - Erkan, Doruk
AU  - Andrade, Danieli
AU  - APS ACTION
PY  - 2021
DO  - 10.1186/s42358-021-00222-3
UR  - https://hdl.handle.net/10668/25857
T2  - Advances in rheumatology (London, England)
AB  - Antiphospholipid syndrome (APS) is characterized by episodes of thrombosis, obstetric morbidity or both, associated with persistently positive antiphospholipid antibodies (aPL). Studying the profile of a rare disease in an admixed population is...
LA  - en
KW  - Anti-beta-2 glycoprotein I antibodies
KW  - Anticardiolipin antibodies
KW  - Antiphospholipid antibodies
KW  - Antiphospholipid syndrome
KW  - Lupus Anticoagulant
KW  - Primary antiphospholipid syndrome
KW  - Antiphospholipid Syndrome
KW  - Brazil
KW  - Clinical Laboratory Techniques
KW  - Databases, Factual
KW  - Female
KW  - Humans
KW  - Lupus Coagulation Inhibitor
KW  - Male
KW  - Risk Factors
TI  - Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository.
TY  - research article
VL  - 61
ER  -